Why is Balloon Dilation Preferred Over Stents for PSC?
At a Glance
For Primary Sclerosing Cholangitis (PSC), balloon dilation is the standard ERCP treatment to open narrowed bile ducts. Routine stenting is avoided because leaving a plastic tube in the duct significantly increases the risk of severe infections and pancreatitis without improving long-term outcomes.
In this answer
5 sections
If you recently had an ERCP (Endoscopic Retrograde Cholangiopancreatography) for a blockage in your bile duct, you might have woken up expecting the doctor to have placed a stent. Because stents are so common in other medical procedures—like opening blocked heart arteries—many people are surprised to learn their doctor simply stretched the bile duct with a balloon and left nothing behind.
For patients with Primary Sclerosing Cholangitis (PSC), using a balloon to stretch a narrowed duct (called balloon dilation) is actually the safest and most recommended first-line treatment [1][2][3]. While stents can be useful in certain situations, leaving a plastic tube in a PSC-affected bile duct dramatically increases the risk of severe infections and complications [1][2][3].
Why Balloon Dilation is the First Choice
During an ERCP for PSC, doctors are usually looking for a dominant stricture—a severely narrowed section of the bile duct that is blocking the flow of bile. To open this stricture, the doctor inflates a small, specialized balloon inside the narrowing to gently stretch the duct back open. During this process, doctors also frequently take brushings or biopsies of the stricture to check for abnormal cells, which is a standard and critical part of evaluating any narrowing in PSC [4][5].
Medical guidelines strongly recommend this balloon dilation as the initial treatment of choice [3][6]. Research consistently shows that stretching the duct with a balloon works just as well as placing a stent to relieve symptoms (like jaundice and itching) and improve bile flow [1][2][3]. In fact, some long-term studies suggest that having scheduled balloon dilations over time may even help protect liver function and delay the need for a liver transplant [7][8][9].
The Hidden Risks of Stents in PSC
It is completely understandable to think that leaving a stent behind would keep the duct propped open better than just stretching it. However, bile duct stents for PSC are typically made of plastic. Metal stents, like those used in the heart, are generally avoided in benign (non-cancerous) strictures because they can become permanently embedded in the bile duct tissue.
Because plastic stents are used instead, routine stenting is actively discouraged for several reasons:
- High Risk of Bacterial Cholangitis (Infection): Plastic stents are foreign objects. Over time, bacteria can build up on the plastic, and the slow-moving bile in a PSC patient can turn to sludge and clog the stent. This blockage frequently leads to bacterial cholangitis, a serious and potentially life-threatening infection of the bile ducts [10][1][11].
- Increased Risk of Pancreatitis: Leaving a stent in place is associated with significantly higher rates of post-ERCP pancreatitis (painful inflammation of the pancreas) compared to balloon dilation alone [1][2][3].
- Equivalent Long-Term Results: Studies comparing patients who got a balloon alone versus a balloon plus a stent show no difference in long-term success or survival rates [2][12]. Because the stent doesn’t offer a better outcome but does add significant risk, doctors prefer to avoid it.
When Are Stents Used in PSC?
There are still times when your doctor might choose to use a stent. Stenting is usually reserved as a backup plan if a stricture is very stubborn (refractory) and immediately collapses after being stretched by a balloon [10][13]. If a stent is placed, it is generally considered a temporary measure. Your doctor will require you to have another ERCP shortly after—usually within a few days to a couple of weeks—to remove or replace the stent before it gets clogged.
What This Means for Your Care
Knowing that balloon dilation is the standard of care can give you peace of mind that your doctor is using the safest approach for your PSC. Because PSC causes progressive scarring, that same stricture may narrow again in the future [14][15]. It is very common for patients to need repeat ERCPs with balloon dilation to keep their bile ducts open and flowing over the years. The timeline for these repeat procedures varies wildly from patient to patient—some may need one every few months, while others go years without needing an intervention.
When to Call Your Doctor
While balloon dilation is the safest option, any ERCP carries baseline risks, including pancreatitis, bleeding, or infection [3]. It is important to monitor your body in the days following the procedure. Call your doctor or seek immediate medical care if you experience any of the following warning signs:
- A new fever or chills (which can indicate an infection or cholangitis)
- Sudden, severe abdominal pain (especially in the upper right side or radiating to your back)
- Returning or worsening jaundice (yellowing of your eyes or skin)
- Persistent vomiting or an inability to keep fluids down
Common questions in this guide
Why didn't my doctor place a stent during my ERCP for PSC?
When is a bile duct stent actually used in PSC?
Will I need to have another ERCP balloon dilation in the future?
What are the warning signs of a complication after an ERCP for PSC?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Did the balloon dilation fully open the dominant stricture, or was there still some narrowing left behind?
- 2.Were brushings or biopsies taken during the ERCP to check for abnormal cells in the bile duct, and when will I receive those results?
- 3.Based on the severity of the stricture you saw during the procedure, how frequently do you recommend I have imaging or ERCPs to monitor my bile ducts?
- 4.If my symptoms (like itching or jaundice) return, should I contact you immediately, or is there a specific threshold for when we would schedule another ERCP?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
Related questions
References
References (15)
- 1
No Superiority of Stents vs Balloon Dilatation for Dominant Strictures in Patients With Primary Sclerosing Cholangitis.
Ponsioen CY, Arnelo U, Bergquist A, et al.
Gastroenterology 2018; (155(3)):752-759.e5 doi:10.1053/j.gastro.2018.05.034.
PMID: 29803836 - 2
Stent versus Balloon Dilation for the Treatment of Dominant Strictures in Primary Sclerosing Cholangitis: A Systematic Review and Meta-Analysis.
Ferreira MTGB, Ribeiro IB, de Moura DTH, et al.
Clinical endoscopy 2021; (54(6)):833-842 doi:10.5946/ce.2021.052.
PMID: 34192839 - 3
A comparison of balloon- versus stent-based approach for dominant strictures in primary sclerosing cholangitis: a meta-analysis.
Dhaliwal AS, Naga Y, Ramai D, et al.
Annals of gastroenterology 2022; (35(3)):307-316 doi:10.20524/aog.2022.0701.
PMID: 35599932 - 4
Role of endoscopy in primary sclerosing cholangitis: European Society of Gastrointestinal Endoscopy (ESGE) and European Association for the Study of the Liver (EASL) Clinical Guideline.
Aabakken L, Karlsen TH, Albert J, et al.
Endoscopy 2017; (49(6)):588-608 doi:10.1055/s-0043-107029.
PMID: 28420030 - 5
Biliary endoscopy in the management of primary sclerosing cholangitis and its complications.
Fung BM, Tabibian JH
Liver research (Beijing, China) 2019; (3(2)):106-117 doi:10.1016/j.livres.2019.03.004.
PMID: 31341699 - 6
Current Therapeutics in Primary Sclerosing Cholangitis.
Tan N, Lubel J, Kemp W, et al.
Journal of clinical and translational hepatology 2023; (11(5)):1267-1281 doi:10.14218/JCTH.2022.00068S.
PMID: 37577219 - 7
Effect of scheduled endoscopic dilatation of dominant strictures on outcome in patients with primary sclerosing cholangitis.
Rupp C, Hippchen T, Bruckner T, et al.
Gut 2019; (68(12)):2170-2178 doi:10.1136/gutjnl-2018-316801.
PMID: 30910856 - 8
Long-term impact of scheduled regular endoscopic interventions for patients with primary sclerosing cholangitis.
Özdirik B, Veltzke-Schlieker W, Nicklaus JM, et al.
Hepatology communications 2024; (8(9)) doi:10.1097/HC9.0000000000000494.
PMID: 39225697 - 9
Impact on follow-up strategies in patients with primary sclerosing cholangitis.
Bergquist A, Weismüller TJ, Levy C, et al.
Liver international : official journal of the International Association for the Study of the Liver 2023; (43(1)):127-138 doi:10.1111/liv.15286.
PMID: 35535655 - 10
New approach to decrease post-ERCP adverse events in patients with primary sclerosing cholangitis.
Navaneethan U, Lourdusamy D, Gutierrez NG, et al.
Endoscopy international open 2017; (5(8)):E710-E717 doi:10.1055/s-0043-102398.
PMID: 28791317 - 11
Endoscopic balloon dilation versus stent placement in the management of dominant strictures in primary sclerosing cholangitis: a systematic review and meta-analysis.
Garg A, Moond V, Garg A, et al.
Gastrointestinal endoscopy 2026; (103(3)):461-468.e14 doi:10.1016/j.gie.2025.08.028.
PMID: 40846243 - 12
Benefit of endoscopic stenting for dominant strictures in patients with primary sclerosing cholangitis.
Han S, Shah RJ
Endoscopy international open 2022; (10(9)):E1163-E1168 doi:10.1055/a-1873-0961.
PMID: 36118630 - 13
Three-months duration of fully-covered metal stent for refractory dominant extra-hepatic biliary stricture among primary sclerosing cholangitis patients: efficacy and safety.
Sbeit W, Khoury T, Goldin E, Mahamid M
Surgical endoscopy 2022; (36(4)):2412-2417 doi:10.1007/s00464-021-08522-x.
PMID: 33977375 - 14
Primary sclerosing cholangitis.
Dyson JK, Beuers U, Jones DEJ, et al.
Lancet (London, England) 2018; (391(10139)):2547-2559 doi:10.1016/S0140-6736(18)30300-3.
PMID: 29452711 - 15
Primary sclerosing cholangitis: review for radiologists.
Morgan MA, Khot R, Sundaram KM, et al.
Abdominal radiology (New York) 2023; (48(1)):136-150 doi:10.1007/s00261-022-03655-6.
PMID: 36063181
This page provides educational information about ERCP procedures for Primary Sclerosing Cholangitis. Always consult your gastroenterologist or hepatologist for medical advice specific to your condition and treatment plan.
Get notified when new evidence is published on Primary sclerosing cholangitis.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.